Medical Device News Magazine

Physica System Trabecular Titanium Tibial Plate – 1st Surgery Performed by Dr. Ivan De Martino

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Physica system Trabecular Titanium Tibial Plate first surgery was performed on  April 29th. Dr. Ivan De Martino performed his first surgery at Agostino Gemelli IRCCS University Hospital Foundation of Rome.

Dr. De Martino is a Hospital for Special Surgery (HSS) fellowship-trained orthopedic surgeon, specializing in complex joint replacement and revision in the Department of Orthopedics directed by prof. Giulio Maccauro. Prior to his current position, Dr. De Martino spent seven years working at HSS and is one of the surgeon designers of this implant.

Upon completing the procedure, Dr. De Martino stated, “The case went well and I’m very satisfied with the outcome. The preparation of the tibial component was quick and easy, and the feeling during impaction was good, the implant was well seated and the fixation rock-solid. The patient was a young male, and I am confident this implant will support his comeback to an active life.”

The Physica system TT Tibial Plate was designed by LimaCorporate in collaboration with the Department of Biomechanics at HSS led by its Director, Timothy Wright, PhD., and Director of Device Development, Joseph Lipman. Headquartered in New York City, HSS is the largest academic medical center specialized in musculoskeletal health and is ranked the #1 hospital in the world for Orthopedics by Newsweek.

“The engineers and surgeons at HSS were delighted to be part of this exciting development effort in close collaboration with our colleagues from LimaCorporate,” stated Dr. Wright.

Embracing the design expertise of HSS and more than 14 years of innovation in 3D printing and clinical history of Trabecular Titanium™ (TT), the Physica system TT Tibial Plate is a state-of-the-art implant that enables LimaCorporate to enter the growing cementless total knee market.

The Physica system TT Tibial Plate is designed to offer a more bone preserving implant with long-term biological fixation compared to standard cemented designs. This will deliver additional benefits to the younger more active patient.

“The use of Trabecular Titanium™ we believe will be a significant advance in cementless total knee design improving osseous integration into the implant and improving outcomes for our patients” stated Dr. Thomas Sculco, Surgeon-in-Chief Emeritus of HSS and one of the surgeon designers of the TT Tibial Plate.

Luigi Ferrari, LimaCorporate CEO, commented: “TT Tibial plate is an important addition to the Physica system and will enable LimaCorporate to approach a new segment of the total knee market. This latest product represents another important milestone for us. I’m excited about the positive impact it will have in helping surgeons to restore the eMotion of motion in their patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”